This grant funds global teams to develop advanced AI agents that work with human researchers to generate and test new cancer research hypotheses, transforming how cancer is studied.
Funder: Cancer Grand Challenges
Due Dates (Anticipated): June 2026: Pre-submission questionnaire deadline (projected) | June 2026: Expression of Interest (EOI) submission deadline (projected) | October 2026: Full application submission deadline (projected)
Funding Amounts: Up to £20 million (~$25 million USD) per award, direct costs only, over up to 5 years; no more than 70% of funds to one country.
Summary: Supports interdisciplinary teams to develop advanced AI agents that collaborate with human researchers to generate and test novel cancer research hypotheses.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
This global grant initiative challenges interdisciplinary teams to develop advanced AI agents that go beyond information extraction and prediction, working collaboratively with human researchers to generate novel hypotheses and design experimental research plans in cancer research. The program aims to foster innovative, paradigm-shifting approaches that integrate and analyze vast, multi-scale cancer data, facilitate complex transdisciplinary questions, and support iterative cycles of experimental validation. Teams must include AI specialists, cancer researchers, data scientists, clinicians, and ethical advisors, with a goal of transforming how cancer is studied and accelerating the discovery of new therapies.